Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 2,469 | 518 | 935 | 1,031 | 2,706 |
| Cost of Goods | 1,416 | 337 | 766 | 421 | 1,126 |
| Gross Profit | 1,053 | 181 | 169 | 610 | 1,580 |
| Operating Expenses | 5,784 | 8,408 | 11,620 | 10,578 | 10,824 |
| Operating Income | -4,315 | -7,890 | -10,685 | -9,547 | -9,118 |
| Interest Expense | 1,085 | 1,260 | 1,085 | 941 | 941 |
| Other Income | -355 | -235 | -58 | 88 | 18 |
| Pre-tax Income | -5,755 | -9,385 | -11,828 | -10,400 | -10,041 |
| Net Income Continuous | -5,755 | -9,385 | -11,828 | -10,400 | -10,041 |
| Net Income | $-5,755 | $-9,385 | $-11,828 | $-10,400 | $-10,041 |
| EPS Basic Total Ops | -0.07 | -0.12 | -0.15 | -0.14 | -0.15 |
| EPS Basic Continuous Ops | -0.05 | -0.12 | -0.15 | -0.14 | -0.15 |
| EPS Diluted Total Ops | -0.07 | -0.12 | -0.15 | -0.14 | -0.15 |
| EPS Diluted Continuous Ops | -0.05 | -0.12 | -0.15 | -0.14 | -0.15 |
| EBITDA(a) | $-3,802 | $-7,310 | $-10,220 | $-9,106 | $-8,369 |